New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioStem Technologies, Inc. (BSEM) vs Citius Pharmaceuticals, Inc. (CTXR)
- BioStem Technologies, Inc. BSEM 0.64 −9.86%
- Citius Pharmaceuticals, Inc. CTXR 0.51 +2.00%
BioStem Technologies, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($13.7M and $13.6M). Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −121.0%) and the lower return on invested capital (−58.7% vs −7.07%). Across the 8 metrics below, Citius Pharmaceuticals, Inc. leads on 5 and BioStem Technologies, Inc. on 3.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack